GGrantIndex
Sort

34,240 grants matching atherosclerosis

Modulators of HDL Structure-Function

$433,550
G M Anantharamaiah · University Of Alabama At Birmingham · P01 · FY2008 · HL

Lmf1 in Lapse expression and lipid Metabolism

$433,530
Miklos Peterfy · University Of California Los Angeles · P01 · FY2014 · HL

ATHEROSCLEROSIS AND PERIPHERAL APOPROTEIN E SYNTHESIS

$433,478
State University New York Stony Brook · R01 · FY2001 · HL

Myeloid cell interactions with T cells in atherosclerosis

$433,460
Klaus F. Ley · La Jolla Institute For Immunology · R01 · FY2016 · HL

ZMPSTE24, HIV treatment regimens, and atherosclerotic heart disease

$433,403
Stephen G Young · University Of California Los Angeles · R01 · FY2015 · HL

IRAS FAMILY STUDY--GENETICS OF INSULIN RESISTANCE

$433,382
University Of Southern California · R01 · FY2000 · HL

MACROPHAGE SCAVENGER RECEPTOR IN ATHEROSCLEROSIS

$433,362
Massachusetts General Hospital · R01 · FY2002 · HL

DISTINCT HUMAN MACROPHAGE RECEPTOR FOR ABNORMAL VLDL

$433,343
University Of Alabama At Birmingham · R01 · FY2002 · HL

Epigenetic regulation of endothelial cell necroptosis impacts vascular integrity

$433,333
Courtney T Griffin · Oklahoma Medical Research Foundation · R01 · FY2017 · HL

Aging, gender and arterial stiffness in atherosclerosis

$433,296
Richard Assoian · University Of Pennsylvania · R01 · FY2018 · AG

Macrophage Akt and IKKalpha signaling in apoptosis and atherosclerosis

$433,276
Macrae F Linton · Vanderbilt University · R01 · FY2013 · HL

02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project

$433,237
David A Ehrmann · University Of Chicago · U01 · FY2017 · DK

DEFENSIN AND THE PATHOGENESIS OF ATHEROSCLEROSIS

$433,221
University Of Pennsylvania · R01 · FY2002 · HL

Diabetes Prevention Program Outcomes Study - Phase 2

$433,214
Mark Ellis Molitch · Northwestern University At Chicago · U01 · FY2012 · DK

Core C: Mouse Breeding & Microsurgery/Procedure Core

$433,208
Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2020 · HL

Hypertension in Hemodialysis Patients

$433,148
Rajiv Agarwal · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2007 · DK

HDL, Inflammation and Atherosclerosis

$433,121
Alan Chait · University Of Washington · P01 · FY2010 · HL

Core C: Mouse Breeding & Microsurgery/Procedure Core

$433,081
Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2019 · HL

Nitroalkenes and Blood Pressure Regulation

$433,068
Yuqing E Chen · University Of Michigan At Ann Arbor · R01 · FY2011 · HL

Myeloid cell interactions with T cells in atherosclerosis

$433,034
Klaus F. Ley · La Jolla Institute For Immunology · R01 · FY2013 · HL

A novel CREBH-derived hepatokine regulates triglyceride metabolism

$432,970
Kezhong Zhang · Wayne State University · R01 · FY2023 · DK

Hyperglycemia and Hyperinsulinemia Induced Procoagulant State

$432,957
Guenther Boden · Temple Univ Of The Commonwealth · R01 · FY2009 · DK

Quantifying the role of load-induced remodeling in lymphedema progression

$432,932
James Brandon Dixon · Georgia Institute Of Technology · R01 · FY2017 · HL

MESA

$432,928
Russell P Tracy · University Of Vermont & St Agric College · N01 · FY2013 · HL

Molecular Characterization of NoxA1 in VSMC NADPH Oxidase Activation

$432,916
Marschall S. Runge · Univ Of North Carolina Chapel Hill · R01 · FY2012 · HL